Is GLMD a good buy?
Isabella Browning
Updated on February 07, 2026
Is GLMD a good buy?
Out of 2 analysts, 1 (50%) are recommending GLMD as a Strong Buy, 1 (50%) are recommending GLMD as a Buy, 0 (0%) are recommending GLMD as a Hold, 0 (0%) are recommending GLMD as a Sell, and 0 (0%) are recommending GLMD as a Strong Sell. What is GLMD’s earnings growth forecast for 2021-2023?
Is galmed Pharmaceuticals a buy?
Galmed Pharmaceuticals has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Is GLMD stock a buy?
Canaccord Genuity is very positive about GLMD and gave it a “Buy” rating on May 24, 2021. The price target was changed from $20.00 to $21.00….Predicted Opening Price for Galmed Pharmaceuticals Ltd. of Wednesday, August 4, 2021.
| Fair opening price August 4, 2021 | Current price |
|---|---|
| $2.84 | $2.80 (Undervalued) |
Will neovasc stock go up?
Will Neovasc stock price grow / rise / go up? Yes. The NVCN stock price can go up from 0.759 USD to 0.976 USD in one year.
Will HTBX go up?
Heat Biologics Inc (NASDAQ:HTBX) The 5 analysts offering 12-month price forecasts for Heat Biologics Inc have a median target of 22.00, with a high estimate of 33.00 and a low estimate of 20.00. The median estimate represents a +231.33% increase from the last price of 6.64.
What happens to stocks under $1?
After the initial listing, if a stock’s average closing price over any 30 consecutive trading days falls below $1, the stock is subject to delisting from the NYSE. This means that a stock can trade for less than $1 at any time, as long as its average closing price stays above $1.
Is HTBX undervalued?
Tangible Asset Value is likely to rise to about 132.4 M in 2021, whereas Free Cash Flow is likely to drop (22.9 M) in 2021. Heat Biologics retains a regular Real Value of $10.37 per share. The prevalent price of the firm is $6.32. At this time, the firm appears to be undervalued….10.37.
| Low | Next Value | High |
|---|---|---|
| 3.58 | 6.21 | 8.84 |
What is the target price for HTBX?
Stock Price Target HTBX
| High | $33.00 |
|---|---|
| Median | $22.00 |
| Low | $15.00 |
| Average | $23.33 |
| Current Price | $6.63 |
What is the market capitalization of Galmed Pharmaceuticals?
Galmed Pharmaceuticals has a market capitalization of $83.03 million and generates $2.04 million in revenue each year. The biopharmaceutical company earns $-28,770,000.00 in net income (profit) each year or ($1.35) on an earnings per share basis.
Is there a public offering of Galmed stock?
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced that it is commencing an underwritten public offering of its Ordinary Shares (the “Offering”).
Where is the mailing address for Galmed Pharmaceuticals?
Galmed Pharmaceuticals’ mailing address is 16 TIOMKIN STREET, TEL AVIV L3, 6578317. The biopharmaceutical company can be reached via phone at 972-3693-8448 or via email at [email protected]
What are research and development expenses for Galmed?
Research and development expenses grew 21.6% year-over-year to $9 million driven by clinical trial costs. General and administrative expenses remained flat at $1.3 million.
